Pharmacogenetic Testing
Pharmacogenetic Testing is a form of clinical genetic testing that analyzes specific genetic variants influencing drug absorption, distribution, metabolism, excretion, or pharmacologic targets in an individual in order to predict medication response and guide the selection and dosing of pharmacotherapy.
3.7K
Publications
221.9K
Citations
18.9K
Authors
4.1K
Institutions
Publications per year
2017–2026
977
Parents
3.7K
The support of human genetic evidence for approved drug indications
Matthew R. Nelson, Hannah Tipney, Jeffery L. Painter et al. · Nature Genetics · 2015 · 1.8K citations
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Tabassome Simon, Céline Verstuyft, Murielle Mary‐Krause et al. · New England Journal of Medicine · 2008 · 1.7K citations · Full text
Medicine, Genetics, Pharmacology +17
1–5 of 3.7K
18.9K
41
h-index
28
h-index
28
h-index
26
h-index
25
h-index
1–5 of 18.9K
4.1K
Stanford University
Stanford, United States
55 h-index
222 publications
37.7K citations

St. Jude Children's Research Hospital
Memphis, United States
53 h-index
356 publications
62.8K citations
Mayo Clinic
Rochester, United States
45 h-index
301 publications
41.6K citations
Harvard University
Cambridge, United States
40 h-index
214 publications
37.5K citations

University of Toronto
Toronto, Canada
38 h-index
157 publications
9.7K citations
University of California, San Francisco
San Francisco, United States
38 h-index
223 publications
22.5K citations

Karolinska Institutet
Stockholm, Sweden
37 h-index
200 publications
15.2K citations
University of Pennsylvania
Philadelphia, United States
36 h-index
173 publications
16.5K citations
1–8 of 4.1K
CPT · 211 publications · 29.1K citations
94
h-index
124 publications · 7.6K citations
50
h-index
235 publications · 8.8K citations
49
h-index
64 publications · 8.4K citations
45
h-index
Repository · 204 publications · 8.9K citations
45
h-index
1–5